RONETTE WISE: Open Payments
NPI 1750391082 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,903 in 146 payments from 17 companies in 2025. Trend: 2023 $1,059 · 2024 $694 · 2025 $2,903
Food & beverage: $2,903
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $616 |
| ABBVIE INC. | 27 | $487 |
| PFIZER INC. | 21 | $279 |
| Lundbeck LLC | 13 | $235 |
| Amgen Inc. | 10 | $235 |
| Otsuka America Pharmaceutical, Inc. | 17 | $221 |
| Novo Nordisk Inc | 8 | $203 |
| Lilly USA, LLC | 2 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $135 |
| Janssen Biotech, Inc. | 1 | $129 |
Products named: REXULTI, AIRSUPRA, VRAYLAR, EVENITY, NURTEC ODT, Wegovy, QULIPTA, UBRELVY.
Industry payments across AR — which companies pay providers there.
